Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of California, Irvine | OTHER |
| University of California, Los Angeles | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.
The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HOPE supervision | Experimental | Parolee supervised under California's new HOPE parole model. |
|
| Parole-as-usual | Active Comparator | Parolees supervised under California parole-as-usual. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HOPE supervision | Behavioral | HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing. |
| Measure | Description | Time Frame |
|---|---|---|
| Days incarcerated | Total number of days incarcerated in jail or prison | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| % positive drug tests | Percentage of random and scheduled drug tests that test positive for illicit drugs | 24 months |
| %Missed | Percentage of parole appointments that are missed. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Angela Hawken, PhD | Pepperdine University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sacramento Metro IV Parole Unit. | Sacramento | California | 95811 | United States |
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Parole-as-usual | Behavioral | Parolees are supervised under standard parole supervision practice in California. |
|
|
| 24 months |
| Revocation rate | Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge. | 24 months |
| New arrests | Number of new arrests. | 24 months |
| Perceptions of risk of detection | Parolees perceived risk of detection for drug use | 24 months |